LY2934747
LY2934747 is a selective and blood-brain barrier-permeable dual mGlu2/mGlu3 receptor agonist, with Ki values of 260 nM and 177 nM, and EC50 values of 8.4 nM and 62.4 nM against human receptors, respectively. LY2934747 exhibits antipsychotic and analgesic activities in in vivo animal models. LY2934747 can be used in studies related to psychosis and pain.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1448707-43-4
- 分子式: C10H13NO4
- 分子量:211.22
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
mGlu2 Receptor |
mGluR3R |
LY2934747 has high aqueous and DMSO solubility, low MDCK permeability, minimal hepatic metabolism, no significant Cyp isoform inhibition, and high plasma unbound fraction across multiple species[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| Species | Dose | Route | AUC0-24 | Cmax | Tmax | T1/2 | Bioavailability | C0 | CL | Vdss |
|---|---|---|---|---|---|---|---|---|---|---|
| Rat[1] | 5 mg/kg | i.v. | 33661 nM·h | / | / | 3.6 h | / | 76749 nM | 11.8 mL/min/kg | 0.57 L/kg |
| Rat[1] | 5 mg/kg | p.o. | 2826 nM·h | 530 nM | 2 h | 3.8 h | 8 % | / | / | / |
| Rat[1] | 1 mg/kg | i.p. | 3050 nM·h | 3580 nM | 0.5 h | 1.1 h | 45 % | / | / | / |
| Rat[1] | 3 mg/kg | i.p. | 7310 nM·h | 10300 nM | 0.5 h | 0.4 h | 36 % | / | / | / |
| Rat[1] | 10 mg/kg | i.p. | 48500 nM·h | 59000 nM | 0.4 h | 1.5 h | 72 % | / | / | / |
LY2934747 (0.3-10 mg/kg; i.p.; single dose) dose-dependently inhibits formalin-induced nociceptive responses in rats, with an ED50 of 0.7 mg/kg[1].
LY2934747 (0.3-10 mg/kg; intraperitoneal injection; single dose) induces motor incoordination in rats at the dose of 10 mg/kg, while this effect is not observed at the dose of 3 mg/kg[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (male, 175-250 g)[1]
-
Dosage:0.3 mg/kg; 1 mg/kg; 3 mg/kg; 10 mg/kg
-
Administration:i.p.; single dose (4 hours prior to PCP challenge)
-
Result:Produced a dose-related reduction in horizontal ambulations.
Achieved statistically significant effects (p < 0.05) at 3 mg/kg and 10 mg/kg.
Reached a calculated ED50 of 1.5 mg/kg.
-
Animal Model:Sprague-Dawley (male, 200-240 g)[1]
-
Dosage:0.3 mg/kg; 1 mg/kg; 3 mg/kg; 10 mg/kg
-
Administration:i.p.; single dose (60 minutes prior to formalin injection)
-
Result:Produced a dose-related decrease in nociceptive responses in both the early (0-5 minutes) and late (11-40 minutes) phases.
Achieved statistically significant effects at 1 mg/kg, 3 mg/kg, and 10 mg/kg.
Reached a calculated ED50 of 0.7 mg/kg.
-
Animal Model:Sprague-Dawley (male)[1]
-
Dosage:3 mg/kg; 10 mg/kg
-
Administration:i.p.; single dose (1, 2, or 3 hours prior to testing)
-
Result:Produced statistically significant locomotor impairment at 10 mg/kg when tested 1, 2, and 3 hours post-administration.
Caused no impairment at the 3 mg/kg dose at any time point.
化学情報
-
CAS 番号 1448707-43-4
-
分子量 211.22
-
分子式 C10H13NO4
-
SMILES
C(O)(=O)[C@H]1[C@@]2(C3(C[C@](C(O)=O)(N)[C@@]21[H])CC3)[H]
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Monn JA, et al. Synthesis and pharmacological characterization of C4-disubstituted analogs of 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: identification of a potent, selective metabotropic glutamate receptor agonist and determination of agonist-bound human mGlu2 and mGlu3 amino terminal domain structures. J Med Chem. 2015 Feb 26;58(4):1776-94. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)